Cargando…
Ablation therapy for ventricular arrhythmias in patients with LVAD: Multiple faces of an electrophysiological challenge
Left ventricular assist device implantation is a recognized treatment option for patients with advanced heart failure refractory to medical therapy and can be used both as bridge to transplantation and as destination therapy. The risk of ventricular arrhythmias is common after left ventricular assis...
Autores principales: | Sisti, Nicolò, Santoro, Amato, Carreras, Giovanni, Valente, Serafina, Donzelli, Stefano, Mandoli, Giulia Elena, Sciaccaluga, Carlotta, Cameli, Matteo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8207352/ https://www.ncbi.nlm.nih.gov/pubmed/34141004 http://dx.doi.org/10.1002/joa3.12542 |
Ejemplares similares
-
COVID-19 in patients with heart failure: the new and the old epidemic
por: Sisti, Nicolò, et al.
Publicado: (2020) -
Biomarkers in Patients with Left Ventricular Assist Device: An Insight on Current Evidence
por: Sciaccaluga, Carlotta, et al.
Publicado: (2022) -
COVID-19 and the burning issue of drug interaction: never forget the ECG
por: Sciaccaluga, Carlotta, et al.
Publicado: (2020) -
Clinical, echocardiographic and hemodynamic predictors of right heart failure after LVAD placement
por: Stricagnoli, M., et al.
Publicado: (2021) -
Left Ventricular Mass with Delayed Enhancement as a Predictor of Major Events in Patients with Myocarditis with Preserved Ejection Fraction
por: Ghionzoli, Nicolò, et al.
Publicado: (2022)